Skip to content

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.

Randomized controlled trial · Psychiatry Res · 2023. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 37540942

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.

Kanaan RA, Oliver G, Dharan A et al.
Psychiatry Res · 2023

PubMed ID
37540942
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.